Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging

Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y, Chen S, Lin X, Zhang G, Xiao H, Dong B.

Front Immunol. 2022 Apr 7;13:796288. doi: 10.3389/fimmu.2022.796288. eCollection 2022.

The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions

Libon DJ, Swenson R, Lamar M, Price CC, Baliga G, Pascual-Leone A, Au R, Cosentino S, Andersen SL.

J Alzheimers Dis. 2022;87(4):1419-1432. doi: 10.3233/JAD-220096.

Targeting Insulin-Like Growth Factor-I in Management of Neurological Disorders

Makkar R, Behl T, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Meraya AM.

Neurotox Res. 2022 Jun;40(3):874-883. doi: 10.1007/s12640-022-00513-7. Epub 2022 Apr 27.

'Fly-ing' from rare to common neurodegenerative disease mechanisms

Ma M, Moulton MJ, Lu S, Bellen HJ.

Trends Genet. 2022 Sep;38(9):972-984. doi: 10.1016/j.tig.2022.03.018. Epub 2022 Apr 25.

Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects

Blanc F, Bousiges O.

Rev Neurol (Paris). 2022 May;178(5):472-483. doi: 10.1016/j.neurol.2022.03.008. Epub 2022 Apr 28.

[Phagocytosis of microglia in neurodegenerative diseases]

Liu YY, DU TS, Liu Y, Zhang Z, Aizier AN, Gong XL, Wang XM, Zhang T.

Sheng Li Xue Bao. 2022 Apr 25;74(2):283-293.

The aging immune system in Alzheimer's and Parkinson's diseases

Heavener KS, Bradshaw EM.

Semin Immunopathol. 2022 Sep;44(5):649-657. doi: 10.1007/s00281-022-00944-6. Epub 2022 May 3.

Repetitive transcranial magnetic stimulation (rTMS) for multiple neurological conditions in rodent animal models: A systematic review

Zong X, Gu J, Geng D, Gao D.

Neurochem Int. 2022 Jul;157:105356. doi: 10.1016/j.neuint.2022.105356. Epub 2022 May 2.

The chaperone Clusterin in neurodegeneration-friend or foe?

Yuste-Checa P, Bracher A, Hartl FU.

Bioessays. 2022 Jul;44(7):e2100287. doi: 10.1002/bies.202100287. Epub 2022 May 6.

Diagnostic accuracy of keystroke dynamics as digital biomarkers for fine motor decline in neuropsychiatric disorders: a systematic review and meta-analysis

Alfalahi H, Khandoker AH, Chowdhury N, Iakovakis D, Dias SB, Chaudhuri KR, Hadjileontiadis LJ.

Sci Rep. 2022 May 11;12(1):7690. doi: 10.1038/s41598-022-11865-7.

Conversion Between the Mini-Mental State Examination and the Montreal Cognitive Assessment for Patients With Different Forms of Dementia

Roheger M, Xu H, Hoang MT, Eriksdotter M, Garcia-Ptacek S.

J Am Med Dir Assoc. 2022 Dec;23(12):1986-1989.e1. doi: 10.1016/j.jamda.2022.03.018. Epub 2022 May 11.

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer's Disease

Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S.

Molecules. 2022 Apr 21;27(9):2680. doi: 10.3390/molecules27092680.

Understanding the contributions of VPS35 and the retromer in neurodegenerative disease

Williams ET, Chen X, Otero PA, Moore DJ.

Neurobiol Dis. 2022 Aug;170:105768. doi: 10.1016/j.nbd.2022.105768. Epub 2022 May 16.

Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis

Liebermann-Jordanidis H, Roheger M, Boosfeld L, Franklin J, Kalbe E.

J Parkinsons Dis. 2022;12(6):1749-1782. doi: 10.3233/JPD-223238.

The role of basket trials in drug development for neurodegenerative disorders

Cummings J, Montes A, Kamboj S, Cacho JF.

Alzheimers Res Ther. 2022 May 25;14(1):73. doi: 10.1186/s13195-022-01015-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias